A detailed history of American Century Companies Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 114,220 shares of AGIO stock, worth $6.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114,220
Previous 94,486 20.89%
Holding current value
$6.57 Million
Previous $4.07 Million 24.55%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$41.19 - $49.72 $812,843 - $981,174
19,734 Added 20.89%
114,220 $5.07 Million
Q2 2024

Aug 07, 2024

BUY
$27.55 - $48.83 $382,118 - $677,272
13,870 Added 17.21%
94,486 $4.07 Million
Q1 2024

May 14, 2024

BUY
$21.32 - $34.81 $389,388 - $635,769
18,264 Added 29.29%
80,616 $2.36 Million
Q4 2023

Feb 13, 2024

BUY
$19.97 - $24.53 $1.25 Million - $1.53 Million
62,352 New
62,352 $1.39 Million
Q3 2023

Nov 13, 2023

BUY
$24.36 - $28.18 $249,957 - $289,154
10,261 Added 28.59%
46,153 $1.14 Million
Q2 2023

Aug 14, 2023

BUY
$21.38 - $29.19 $227,333 - $310,377
10,633 Added 42.1%
35,892 $1.02 Million
Q1 2023

May 11, 2023

BUY
$21.74 - $30.93 $102,525 - $145,865
4,716 Added 22.96%
25,259 $580,000
Q4 2022

Feb 13, 2023

BUY
$24.81 - $31.52 $296,504 - $376,695
11,951 Added 139.09%
20,543 $576,000
Q3 2022

Nov 14, 2022

BUY
$19.51 - $34.14 $167,629 - $293,330
8,592 New
8,592 $243,000
Q4 2019

Feb 12, 2020

SELL
$30.08 - $50.59 $1.4 Million - $2.35 Million
-46,472 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$32.4 - $49.58 $2.37 Million - $3.62 Million
-73,054 Reduced 61.12%
46,472 $1.51 Million
Q2 2019

Aug 14, 2019

BUY
$46.17 - $68.1 $369,360 - $544,800
8,000 Added 7.17%
119,526 $5.96 Million
Q1 2019

May 14, 2019

BUY
$45.92 - $67.67 $650,227 - $958,207
14,160 Added 14.54%
111,526 $0
Q4 2018

Feb 13, 2019

BUY
$42.73 - $76.53 $4.16 Million - $7.45 Million
97,366 New
97,366 $4.49 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.15B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.